Literature DB >> 3802932

Bronchoalveolar lavage in amiodarone pneumonitis. Cellular abnormalities and their relevance to pathogenesis.

D Israël-Biet, A Venet, I Caubarrère, G Bonan, C Danel, J Chrétien, A J Hance.   

Abstract

To investigate the contribution of direct cytotoxicity and immune-mediated hypersensitivity to the pathogenesis of amiodarone pneumonitis, we evaluated cells recovered by bronchoalveolar lavage from 13 patients with amiodarone pneumonitis. Alveolar macrophages from all patients contained two types of abnormal inclusions: small clear vacuoles and large phagolysosomes containing phospholipid in lamellar structures, abnormalities previously attributed to direct cytotoxicity from amiodarone. However, these changes were always associated with abnormalities in the numbers and types of immune and inflammatory cells present in the lower respiratory tract, which closely resemble those seen in hypersensitivity pneumonitis associated with inhaled antigens. Following discontinuation of amiodarone and institution of corticosteroid therapy, clinical improvement correlated with a return toward normal in the pattern of inflammatory cells present in the lung, although alveolar macrophages continued to display evidence of drug-induced cytotoxicity. These findings support the possibility that a cell-mediated immune response usually plays a role in the pathogenesis of amiodarone pneumonitis, although direct cytotoxicity may predispose these patients to the development of this abnormal immune response.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3802932     DOI: 10.1378/chest.91.2.214

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  10 in total

1.  Susceptibility to amiodarone-induced pulmonary toxicity: relationship to the uptake of amiodarone by isolated lung cells.

Authors:  B D Wilson; M L Lippmann
Journal:  Lung       Date:  1996       Impact factor: 2.584

2.  Amiodarone-induced pulmonary toxicity in the rat.

Authors:  B D Wilson; A J Jaworski; M E Donner; M L Lippmann
Journal:  Lung       Date:  1989       Impact factor: 2.584

Review 3.  Amiodarone: review of pulmonary effects and toxicity.

Authors:  Spyros A Papiris; Christina Triantafillidou; Likurgos Kolilekas; Despoina Markoulaki; Effrosyni D Manali
Journal:  Drug Saf       Date:  2010-07-01       Impact factor: 5.606

4.  Pulmonary complications after long term amiodarone treatment.

Authors:  J Roca; M Heras; R Rodriguez-Roisin; J Magriñà; A Xaubet; G Sanz
Journal:  Thorax       Date:  1992-05       Impact factor: 9.139

5.  Amiodarone causes decreased cell-mediated immune responses and inhibits the phospholipase C signaling pathway.

Authors:  B D Wilson; C E Clarkson; M L Lippmann
Journal:  Lung       Date:  1993       Impact factor: 2.584

6.  Toxicity of orally inhaled drug formulations at the alveolar barrier: parameters for initial biological screening.

Authors:  Eleonore Fröhlich
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

Review 7.  Drug-Induced Interstitial Lung Disease: A Systematic Review.

Authors:  Sarah Skeoch; Nicholas Weatherley; Andrew J Swift; Alexander Oldroyd; Christopher Johns; Conal Hayton; Alessandro Giollo; James M Wild; John C Waterton; Maya Buch; Kim Linton; Ian N Bruce; Colm Leonard; Stephen Bianchi; Nazia Chaudhuri
Journal:  J Clin Med       Date:  2018-10-15       Impact factor: 4.241

8.  A Case Series of Vaping-Associated Lung Injury Requiring Mechanical Ventilation.

Authors:  June Choe; Peter Chen; Jeremy A Falk; Luan Nguyen; David Ng; Tanyalak Parimon; Sara Ghandehari
Journal:  Crit Care Explor       Date:  2020-01-29

Review 9.  Statin-induced lung injury: diagnostic clue and outcome.

Authors:  Li-Kuo Huang; Ming-Ji Tsai; Han-Chen Tsai; Heng-Sheng Chao; Fang-Chi Lin; Shi-Chuan Chang
Journal:  Postgrad Med J       Date:  2012-10-05       Impact factor: 2.401

10.  Attenuation of amiodarone induced lung fibrosis and phospholipidosis in hamsters, by treatment with the platelet activating factor receptor antagonist, WEB 2086.

Authors:  S N Giri; D M Hyde; D R Haynam; M Casias
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.